The worldwide market for cancer immunotherapies is anticipated to grow from $1.1B in 2012 to $9B in 2022, that equals a 23/8% annual growth. Leading the growth are the immune checkpoint inhibitors.
Cancer Immunotherapy Projections – Immune Checkpoint Inhibitors lead the way
Leave a reply